Survival of ovarian cancer patients in Denmark: Results from the Danish gynaecological cancer group (DGCG) database, 1995-2012

被引:20
|
作者
Edwards, Hellen McKinnon [1 ]
Noer, Mette Calundann [2 ]
Sperling, Cecilie Dyg [3 ]
Nguyen-Nielsen, Mary [4 ,5 ]
Lundvall, Lene [2 ]
Christensen, Ib Jarle [6 ]
Hogdall, Claus [2 ]
机构
[1] Univ Copenhagen, Dept Obstet & Gynaecol, Herlev Hosp, Herlev Ringvej 75, DK-2730 Herlev, Denmark
[2] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, Dept Gynecol, Copenhagen, Denmark
[3] Danish Canc Soc, Documentat & Qual, Copenhagen, Denmark
[4] Aarhus Univ Hosp Skejby, Dept Urol, Aarhus, Denmark
[5] Danish Canc Soc Res Ctr, Diet Genes & Environm, Copenhagen, Denmark
[6] Univ Copenhagen, Herlev Hosp, Dept Pathol, Herlev, Denmark
关键词
CO-MORBIDITY; POPULATION; STAGE; REGISTRY; AGE;
D O I
10.1080/0284186X.2016.1182641
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Ovarian cancer has a high mortality rate, especially in Denmark where mortality rates have been reported higher than in adjacent countries with similar demographics. This study therefore examined recent survival and mortality among Danish ovarian cancer patients over an 18-year study period.Methods: This nationwide registry-based observational study used data from the Danish Gynecology Cancer Database, Danish Pathology Registry, and Danish National Patient Registry. All patients with ovarian cancer diagnosed between 1995 and 2012 were included in the study. The data sources were linked via the patients' personal identification number and the analyses included data on cancer stage, age, survival, surgery status and comorbidity. The computed outcome measures were age-adjusted mortality rates and age-adjusted overall and relative survival rates for one and five years.Results: We identified 9972 patients diagnosed with ovarian cancer in the period 1995-2012. The absolute one-year mortality rate decreased from 42.8 (CI 40.3-45.6) in 1995-1999 to 28.3 (CI 25.9-30.9) in 2010-2012, and the five-year mortality rate decreased from 28.2 (CI 27.0-29.5) in 1995-1999 to 23.9 (CI 22.9-25.0) in 2005-2009. After stratification by age, comorbidity and cancer stage, the decrease in one-year mortality was most substantial in the 65-74 year old age group 41.1 (CI 38.8-43.5) to 26.5 (CI 24.4-28.7) and for stage III 39.1 (CI 35.1-43.6) to 22.9 (CI 19.9-26.5) and stage IV 91.3 (CI 80.8-103.2) to 41.9 (CI 35.5-49.5). For overall survival, we showed an increase in one-year survival from 68% (CI 66-69%) in 1995-1999 to 76% (CI 74-78%) in 2010-2012 and an increase in five-year survival from 33% (CI 32-35%) in 1995-1999 to 36% (CI 34-38%) in 2005-2009. Relative survival showed similar increases through the period.Conclusions: Ovarian cancer survival in Denmark has improved substantially from 1995 to 2012, bringing Denmark closer to the standards set by adjacent countries.
引用
收藏
页码:36 / 43
页数:8
相关论文
共 50 条
  • [41] Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
    Moller, Pal
    Seppala, Toni
    Bernstein, Inge
    Holinski-Feder, Elke
    Sala, Paola
    Evans, D. Gareth
    Lindblom, Annika
    Macrae, Finlay
    Blanco, Ignacio
    Sijmons, Rolf
    Jeffries, Jacqueline
    Vasen, Hans
    Burn, John
    Nakken, Sigve
    Hovig, Eivind
    Rodland, Einar Andreas
    Tharmaratnam, Kukatharmini
    Cappel, Wouter H. de Vos Tot Nederveen
    Hill, James
    Wijnen, Juul
    Green, Kate
    Lalloo, Fiona
    Sunde, Lone
    Mints, Miriam
    Bertario, Lucio
    Pineda, Marta
    Navarro, Matilde
    Morak, Monika
    Renkonen-Sinisalo, Laura
    Frayling, Ian M.
    Plazzer, John-Paul
    Pylvanainen, Kirsi
    Sampson, Julian R.
    Capella, Gabriel
    Mecklin, Jukka-Pekka
    Moslein, Gabriela
    GUT, 2017, 66 (03) : 464 - 472
  • [42] Limited prognostic value of tissue protein expression levels of BCl-2 in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study
    Hogdall, Estrid V. S.
    Christensen, Lise
    Kjaer, Susanne K.
    Blaakaer, Jan
    Christensen, Ib Jarle
    Hogdall, Claus K.
    APMIS, 2010, 118 (08) : 557 - 564
  • [43] Diet quality and survival after ovarian cancer: results from an ovarian cancer follow-up study (OOPS)
    Li, Xin-Yu
    Liu, Chuan
    Liu, Fang-Hua
    Zheng, Gang
    Yang, Hui-Juan
    Wei, Yi-Fan
    Qin, Xue
    Xiao, Qian
    Zhao, Yu-Hong
    Gao, Song
    Gong, Ting-Ting
    Wu, Qi-Jun
    FOOD & FUNCTION, 2023, 14 (12) : 5644 - 5652
  • [44] Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium
    Dixon, Suzanne C.
    Nagle, Christina M.
    Wentzensen, Nicolas
    Trabert, Britton
    Beeghly-Fadiel, Alicia
    Schildkraut, Joellen M.
    Moysich, Kirsten
    deFazio, Anna
    Risch, Harvey A.
    Rossing, Mary Anne
    Doherty, Jennifer A.
    Wicklund, Kristine G.
    Goodman, Marc T.
    Modugno, Francesmary
    Ness, Roberta B.
    Edwards, Robert P.
    Jensen, Allan
    Kjaer, Susanne K.
    Hogdall, Estrid
    Berchuck, Andrew
    Cramer, Daniel W.
    Terry, Kathryn L.
    Poole, Elizabeth M.
    Bandera, Elisa V.
    Paddock, Lisa E.
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Menon, Usha
    Gayther, Simon A.
    Ramus, Susan J.
    Gentry-Maharaj, Aleksandra
    Pearce, Celeste Leigh
    Wu, Anna H.
    Pike, Malcolm C.
    Webb, Penelope M.
    BRITISH JOURNAL OF CANCER, 2017, 116 (09) : 1223 - 1228
  • [45] Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium
    Suzanne C Dixon
    Christina M Nagle
    Nicolas Wentzensen
    Britton Trabert
    Alicia Beeghly-Fadiel
    Joellen M Schildkraut
    Kirsten B Moysich
    Anna deFazio
    Harvey A Risch
    Mary Anne Rossing
    Jennifer A Doherty
    Kristine G Wicklund
    Marc T Goodman
    Francesmary Modugno
    Roberta B Ness
    Robert P Edwards
    Allan Jensen
    Susanne K Kjær
    Estrid Høgdall
    Andrew Berchuck
    Daniel W Cramer
    Kathryn L Terry
    Elizabeth M Poole
    Elisa V Bandera
    Lisa E Paddock
    Hoda Anton-Culver
    Argyrios Ziogas
    Usha Menon
    Simon A Gayther
    Susan J Ramus
    Aleksandra Gentry-Maharaj
    Celeste Leigh Pearce
    Anna H Wu
    Malcolm C Pike
    Penelope M Webb
    British Journal of Cancer, 2017, 116 : 1223 - 1228
  • [46] Aspects of Therapy for Cervical Cancer in Germany 2012-Results from a Survey of German Gynaecological Hospitals
    Mangler, M.
    Zech, N.
    Schneider, A.
    Koehler, C.
    Marnitz, S.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2013, 73 (03) : 227 - 238
  • [47] Patient-reported outcome measures in prostate cancer: results from the Danish prostate cancer database (Daproca Data)
    Nielsen, Mary Nguyen
    Tjonneland, Anne
    Moller, Henrik
    Borre, Michael
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 : 25 - 25
  • [48] A machine learning approach applied to gynaecological ultrasound to predict progression-free survival in ovarian cancer patients
    Arezzo, F.
    Loizzi, V.
    Cazzato, G.
    Venerito, V.
    Cicinelli, E.
    Cormio, G.
    Santarsiero, C. M.
    ANNALS OF ONCOLOGY, 2021, 32 : S746 - S746
  • [49] Potential impact of dietary intervention/counseling on survival in ovarian cancer patients: Results from an observational study
    Michalak, Jessica
    Hernandez, Mike
    Laws, Alexandria
    Jones, Lovell
    Bodurka, Diane C.
    Hajek, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Pancreatic cancer: A report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database
    Sener, SF
    Fremgen, A
    Menck, HR
    Winchester, DP
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1999, 189 (01) : 1 - 7